glp-1 obesity drug news today october 23 2025 RA Weight Loss Drugs May Carry Untold Ocular Burden What is the pipeline for
Description
Zepbound (tirzepatide) Approved - A once-weekly injectable medication approved by the FDA in November 2023 for chronic weight management
10.3390/ijms20071584 11 ChouC
Garabadu D, Verma J
33 The basic information of the article was recorded, including the first author, publication date, sample size, average age, and sex of the patients, type of study design, diagnostic criteria for AD, intervention methods, and assessment methods of cognitive function
2020;3(5) doi: 10.1001/jamanetworkopen.2020.4803
